Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nanfang Hospital, Southern Medical University
University of Washington
St. Jude Children's Research Hospital
University of California, San Diego
Universität des Saarlandes
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Washington
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
SWOG Cancer Research Network
Children's Oncology Group
University of Southern California
National Cancer Institute (NCI)
Centre Henri Becquerel
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center